Alastair Riddell Net Worth

Alastair Riddell biography

Dr. Alastair Riddell serves as Independent Director of the Company. Dr. Riddell has served as Chair of Nemesis Biosciences Ltd and Chair of Feedback plc (LON: FDBK). He has also served as Chair of the South West Academic Health Science network in the UK since January 2016. Since his appointment in December 2015, Dr. Riddell has served as Non-Executive Director of Cristal Therapeutics in The Netherlands. From September 2012 to February 2016, he served as Chair of Definigen Ltd., and from November 2013 to September 2015 as Chair of Silence Therapeutics Ltd., and from October 2009 to November 2012 as Chair of Procure Therapeutics. Between 2007 to 2009, Dr. Riddell served as the Chief Executive Officer of Stem Cell Sciences plc. and between 2005 to 2007, served at Paradigm Therapeutics Ltd. as the Chief Executive Officer. Between 1998 to 2005, Dr. Riddell also served as the Chief Executive Officer of Pharmagene plc. Dr. Ridell began his career as a doctor in general practice in a variety of hospital specialties and holds a Master of Science and a Bachelor of Medicine and Surgery degrees. He was recently awarded a Doctorate of Science, Honoris Causa by Aston University.

What is the salary of Alastair Riddell?

As the Independent Director of AzurRx BioPharma Inc, the total compensation of Alastair Riddell at AzurRx BioPharma Inc is $148,750. There are 3 executives at AzurRx BioPharma Inc getting paid more, with James R. Sapirstein R.Ph., M.B.A. having the highest compensation of $622,005.

How old is Alastair Riddell?

Alastair Riddell is 71, he's been the Independent Director of AzurRx BioPharma Inc since 2015. There are 3 older and 5 younger executives at AzurRx BioPharma Inc. The oldest executive at AzurRx BioPharma Inc is Vern Schramm, 78, who is the Independent Director.

What's Alastair Riddell's mailing address?

Alastair's mailing address filed with the SEC is C/O AZURRX BIOPHARMA, INC., 1615 SOUTH CONGRESS AVENUE, SUITE 103, DELRAY BEACH, FL, 33445.

Insiders trading at AzurRx BioPharma Inc

Over the last 8 years, insiders at AzurRx BioPharma Inc have traded over $510,400 worth of AzurRx BioPharma Inc stock and bought 335,700 units worth $727,436 . The most active insiders traders include Charles J Casamento, Edmund Burke Jr. Ross, and Partners Llcbalk Matthew Pe.... On average, AzurRx BioPharma Inc executives and independent directors trade stock every 82 days with the average trade being worth of $262,052. The most recent stock trade was executed by Johan M. Spoor on 28 December 2018, trading 38,583 units of AZRX stock currently worth $50,158.

What does AzurRx BioPharma Inc do?

AzurRx BioPharma Inc executives and stock owners

AzurRx BioPharma Inc executives and other stock owners filed with the SEC include:

• James R. Sapirstein R.Ph., M.B.A.,
  CEO, Pres & Non-Independent Director
• James Pennington,
  Chief Medical Officer
• James Sapirstein,
  President, Chief Executive Officer, Director
• Alastair Riddell,
  Independent Director
• Edward Borkowski,
  Independent Chairman of the Board
• Vern Schramm,
  Independent Director
• Charles Casamento,
  Independent Director
• Gregory Oakes,
  Independent Director
• Daniel Schneiderman,
  Chief Financial Officer
• Martin Krusin M.B.A.,
  Sr. VP of Corp. Devel.
• Johan M. Spoor,
  
• Partners Llcbalk Matthew Pe...,
  
• Edmund Burke Jr. Ross,
  
• Maged Shenouda,
  CHIEF FINANCIAL OFFICER
• Daniel Dupret,
  CHIEF SCIENTIFIC OFFICER
• Mary Theresa Coelho,